RxDoctor Payments Data

Joseph Raniere, MD

Plastic Surgery · Fayetteville, GANPI 1891787586

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,824 of the $6,181 with a category attached, or 61.9%. 19 manufacturers reported payments, led by TELA Bio, Inc. at 36.4% of the total. 2025 is the largest year on record at $3,201, more than ten times the $157 reported in 2019.

$6,181in general payments, 2019–2025

Across 131 payments — averaging $47.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • TELA Bio, Inc.$2K
  • AbbVie$2K
  • Integra Lifesciences Corporation$551
  • Mentor Worldwide LLC$362
  • Musculoskeletal Transplant Foundation Inc.$306
  • Motiva USA, LLC$170
  • plus $517 from 13 others
$19,907in research payments, 2019–2025

Across 12 payments — averaging $1658.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$12K
  • Medical Device Business Services, Inc.$8K

What the payments were for

  • Travel & lodging$2,03133%
  • Food & beverage$3,82462%
  • Other$3265%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,181 in reported general payments places this provider in the 70th percentile of 163 plastic surgery providers in Georgia.

See all plastic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$37,795
Medicare patients
45
Services billed
138

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ArexvyRsvpref3 Antigen/As01e/Pf60$17,873
ShingrixVaricella-Zoster Ge/As01b/Pf58$12,395
Boostrix TdapDiphth,pertuss(Acell),tet Vac11$727
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$334
Cephalexin53$333
Scopolamine16$190
Promethazine Hcl35$106
Tramadol Hcl12$21
Famotidine12$13
Metoclopramide Hcl13$13

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Fayetteville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →